Study | Disease | Estimate from source | Estimate in Fig. 1 of Glantz et al. [14] |
---|---|---|---|
Alzahrani [34] | MI | 0.66 (0.43–1.02) | Same |
Falk [23] | 0.35 (0.19–0.63) | 0.35 (0.19–0.62) | |
Farsalinos [33] | 0.43 (0.25–0.75) | Only gave CHD estimate | |
Goldberg Scott [26] | Not available1 | No | |
Hirschtick [24] | 0.31 (0.06–1.60) | 0.30 (0.04–2.22) | |
Pooled | 0.48 (0.35–0.67) | Same2 | |
Bricknell [35] | Stroke | 0.77 (0.54–1.10) | Same |
Falk [23] | 0.50 (0.27–0.92) | 0.50 (0.33–0.77) | |
Goldberg Scott [26] | Not available1 | No | |
Hirschtick [24] | 0.77 (0.23–2.61) | 0.77 (0.25–2.38) | |
Parekh [36] | 0.43 (0.20–0.95) | 0.43 (0.18–1.04) | |
Pooled | 0.65 (0.49–0.86) | 0.62 (0.48–0.82) | |
Antwi [39] | COPD | 0.32 (0.23–0.45) | 0.32 (0.22–0.47) |
Barrameda [40] | 0.76 (0.31–1.89) | No | |
Cook [42] | 0.67 (0.42–1.09) | 0.67 (0.39–1.17) | |
Kim [44] | Not available3 | No | |
Osei [45] | Not available1 | No | |
Parekh [46] | 0.42 (0.21–0.84) | 0.42 (0.17–1.01) | |
Paulin [47] | 0.71 (0.26–1.91) | 0.71 (0.23–2.23) | |
Perez [48] | Not available1 | No | |
Wills [49] | 0.87 (0.44–1.71) | 0.86 (0.46–1.61) | |
Wills [50] | 0.31 (0.26–0.38) | Same | |
Xie [52] | 0.39 (0.27–0.56) | 0.39 (0.25–0.62) | |
Pooled | 0.46 (0.35–0.60) | 0.46 (0.35–0.62)4 |